A detailed history of Fin Trust Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 1,909 shares of LLY stock, worth $1.68 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
1,909
Previous 2,007 4.88%
Holding current value
$1.68 Million
Previous $1.56 Million 10.7%
% of portfolio
0.33%
Previous 0.31%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$724.87 - $909.04 $71,037 - $89,085
-98 Reduced 4.88%
1,909 $1.73 Million
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $190,096 - $254,321
321 Added 19.04%
2,007 $1.56 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $18,381 - $21,669
-35 Reduced 2.03%
1,686 $982,000
Q3 2023

Oct 24, 2023

SELL
$434.7 - $599.3 $34,776 - $47,944
-80 Reduced 4.44%
1,721 $924,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $20,257 - $23,604
-63 Reduced 3.38%
1,801 $658,000
Q3 2022

Oct 20, 2022

SELL
$296.48 - $337.87 $5,336 - $6,081
-18 Reduced 0.96%
1,864 $625,000
Q2 2022

Jul 26, 2022

BUY
$278.73 - $327.27 $18,396 - $21,599
66 Added 3.63%
1,882 $619,000
Q1 2022

May 03, 2022

BUY
$234.69 - $291.66 $32,152 - $39,957
137 Added 8.16%
1,816 $519,000
Q3 2021

Nov 16, 2021

BUY
$221.6 - $272.71 $14,847 - $18,271
67 Added 4.16%
1,679 $388,000
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $44,747 - $59,212
-343 Reduced 17.54%
1,612 $272,000
Q2 2020

Sep 11, 2020

BUY
$136.42 - $164.18 $266,701 - $320,971
1,955 New
1,955 $321,000
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $245,555 - $295,524
-1,800 Closed
0 $0
Q2 2019

Aug 01, 2019

SELL
$110.79 - $129.32 $18,501 - $21,596
-167 Reduced 8.49%
1,800 $199,000
Q1 2019

May 09, 2019

SELL
$111.31 - $131.02 $55,988 - $65,903
-503 Reduced 20.36%
1,967 $256,000
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $261,573 - $293,040
2,470 New
2,470 $286,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.